Roche shares drop 5% as breast cancer drug giredestrant fails clinical trial
Roche shares drop 5% as breast cancer drug giredestrant fails clinical trialSource: Investing.com
أخبار الاستثمار والأسواق المالية من موقع Investing.com
Roche shares drop 5% as breast cancer drug giredestrant fails clinical trialSource: Investing.com

Short positions in U.S. ETFs record biggest weekly rise since Liberation DaySource: Investing.com

Equity positioning falls below neutral as funds cut allocations: DBSource: Investing.com
Hims soars 44% on report Novo Nordisk to sell weight-loss drugs on its platformSource: Investing.com

Nvidia-backed Nscale valued at $14.6 billion in fresh funding roundSource: Reuters

British government bonds drop as oil surge revives inflation fearsSource: Investing.com

FTSE 100 today: UK stocks open lower, pound at $1.33; oil tops $100 amid conflictSource: Investing.com
European stocks slip as oil prices spike amid ongoing Iran conflictSource: Investing.com

JPM warns Mideast crisis could hurt UAE markets, prefers Saudi stocksSource: Investing.com

JPMorgan turns bearish on EMEA mining, steel stocks amid Middle East risksSource: Investing.com